Utilization Management
Prescription Drug Prior Authorization and Step Therapy Policies for Cascade Select Marketplace Business
Not all medications will be covered on the formulary. Non-formulary medications are subject to the Medical Necessity for Non-Formulary Medications policy. Please consult the formulary to verify coverage.
| Metabolic Disorders - Dojolvi PA Policy | Policy |
| Metabolic Disorders - Imcivree DQM Policy - Per Days | Policy |
| Metabolic Disorders - Imcivree PA Policy | Policy |
| Metabolic Disorders - Nitisinone Products PA Policy | Policy |
| Metabolic Disorders - Nulibry PA Policy | Policy |
| Metabolic Disorders - Phenylbutyrate Products PA Policy | Policy |
| Metabolic Disorders - Primary Hyperoxaluria - Oxlumo PA Policy | Policy |
| Metabolic Disorders - Primary Hyperoxaluria - Oxlumo PA Policy-1 | Policy |
| Metabolic Disorders - Tiopronin Products PA Policy | Policy |
| Metabolic Disorders - Xuriden PA Policy | Policy |
| Methotrexate Injection Step Therapy Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Aimovig PA Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Ajovy PA Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Ajovy PA Policy-1 | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Emgality PA Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Emgality PA Policy-1 | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Vyepti PA Policy | Policy |
| Migraine - Elyxyb PA Policy | Policy |
| Migraine - Nurtec ODT PA Policy | Policy |
| Migraine - Qulipta PA Policy | Policy |
| Migraine - Reyvow PA Policy | Policy |
| Migraine - Triptans DQM Policy - Per Days | Policy |
| Migraine - Triptans DQM Policy - Per Days-1 | Policy |
| Migraine - Triptans DQM Policy - Per Rx | Policy |
| Migraine - Triptans DQM Policy - Per Rx-1 | Policy |
| Migraine - Ubrelvy PA Policy | Policy |
| Migraine Medication Step Therapy Policy | Policy |
| Migraine Medication Step Therapy Policy-1 | Policy |
| Migraine Medication Step Therapy Policy-2 | Policy |
| Multiple Sclerosis - CD20-Directed Cytolytic Antibody Infused Products PSM Policy | Policy |
| Multiple Sclerosis - Dalfampridine PA Policy | Policy |
| Multiple Sclerosis - Dalfampridine PSM Policy | Policy |
| Multiple Sclerosis - Kesimpta DQM Policy - Per Days | Policy |
| Multiple Sclerosis - Kesimpta DQM Policy - Per Days-1 | Policy |
| Multiple Sclerosis - Lemtrada DQM Policy - Per Days | Policy |
| Multiple Sclerosis - Ocrevus and Ocrevus Zunovo DQM Policy - Per Days | Policy |
| Multiple Sclerosis - Ponvory DQM Policy - Per Days | Policy |
| Multiple Sclerosis - Ponvory DQM Policy - Per Days-1 | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Avonex PA Policy | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Avonex PA Policy-1 | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Betaseron PA Policy | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Betaseron PA Policy-1 | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Plegridy PA Policy | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Plegridy PA Policy-1 | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Rebif PA Policy | Policy |
| Multiple Sclerosis (Injectable - Beta Interferon) - Rebif PA Policy-1 | Policy |
| Multiple Sclerosis (Injectable - CD20-Directed Cytolytic Antibody) - Briumvi PA Policy | Policy |
| Multiple Sclerosis (Injectable - CD20-Directed Cytolytic Antibody) - Kesimpta PA Policy | Policy |
| Multiple Sclerosis (Injectable - CD20-Directed Cytolytic Antibody) - Kesimpta PA Policy-1 | Policy |
| Multiple Sclerosis (Injectable - CD20-Directed Cytolytic Antibody) - Ocrevus PA Policy | Policy |
| Multiple Sclerosis (Injectable - Other) - Lemtrada PA Policy | Policy |
| Multiple Sclerosis (Injectable) - Glatiramer Products PA Policy | Policy |
| Multiple Sclerosis (Injectable) - Glatiramer Products PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Bafiertam PA Policy | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Bafiertam PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Dimethyl Fumarate PA Policy | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Dimethyl Fumarate PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Vumerity PA Policy | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Vumerity PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Other) - Mavenclad PA Policy | Policy |
| Multiple Sclerosis (Oral - Other) - Mavenclad PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Other) - Teriflunomide PA Policy | Policy |
| Multiple Sclerosis (Oral - Other) - Teriflunomide PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Fingolimod PA Policy | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Fingolimod PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Mayzent PA Policy | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Mayzent PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Ponvory PA Policy | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Ponvory PA Policy-1 | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Tascenso ODT PA Policy | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Tascenso ODT PA Policy-1 | Policy |
| Multiple Sclerosis and Crohn's Disease (Injectable - Other) - Natalizumab Products PA Policy | Policy |
| Multiple Sclerosis and Crohn's Disease (Injectable - Other) - Tysabri PA Policy | Policy |
| Multiple Sclerosis and Ulcerative Colitis - Zeposia PSM Policy for National Preferred, High Performance, and Basic - Choice, Alternate-1 | Policy |
| Multiple Sclerosis and Ulcerative Colitis - Zeposia PSM Policy for National Preferred, High Performance, and Basic - Choice, Alternate | Policy |
| Multiple Sclerosis and Ulcerative Colitis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Zeposia PA Policy | Policy |
| Multiple Sclerosis and Ulcerative Colitis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Zeposia PA Policy-1 | Policy |
| Multiple Sclerosis PSM Policy | Policy |
| Multiple Sclerosis PSM Policy-1 | Policy |
| Multiple Sclerosis PSM Policy-2 | Policy |
| Muscular Dystrophy - Amondys 45 PA Policy | Policy |
| Muscular Dystrophy - Deflazacort PA Policy | Policy |
| Muscular Dystrophy - Deflazacort PA Policy-1 | Policy |
| Muscular Dystrophy - Deflazacort PA Policy-2 | Policy |
| Muscular Dystrophy - Deflazacort PA Policy-3 | Policy |
| Muscular Dystrophy - Deflazacort PSM Policy | Policy |
| Muscular Dystrophy - Deflazacort PSM Policy-1 | Policy |
| Muscular Dystrophy - Exondys 51 PA Policy | Policy |
| Muscular Dystrophy - Viltepso PA Policy | Policy |
| Muscular Dystrophy - Vyondys 53 PA Policy | Policy |
| Muscular Dystrophy - Vyondys 53 PA Policy-1 | Policy |
| Nasal Steroids Step Therapy Policy | Policy |
| Nephrology - Filspari PA Policy | Policy |
| Nephrology - Filspari PA Policy-1 | Policy |
| Nephrology - Filspari PA Policy-2 | Policy |
| Nephrology - Tarpeyo PA Policy | Policy |
| Neurology - Brineura PA Policy | Policy |
| Neurology - Edaravone Products PA Policy | Policy |
| Neurology - Edaravone Products PA Policy-1 | Policy |
| Neurology - Gene Therapy - Skysona PA Policy | Policy |